ZA881122B - Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders - Google Patents

Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders

Info

Publication number
ZA881122B
ZA881122B ZA881122A ZA881122A ZA881122B ZA 881122 B ZA881122 B ZA 881122B ZA 881122 A ZA881122 A ZA 881122A ZA 881122 A ZA881122 A ZA 881122A ZA 881122 B ZA881122 B ZA 881122B
Authority
ZA
South Africa
Prior art keywords
agents
substituted heterocyclic
heterocyclic compounds
treating coronary
cerebral disorders
Prior art date
Application number
ZA881122A
Other languages
English (en)
Inventor
Gerd Schnorrenberg
Schnorrenberg Gerd
Otto Roos
Roos Otto
Walter Loesel
Loesel Walter
Dietrich Arndts
Arndts Dietrich
Georg Speck
Speck Georg
Ilse Streller
Streller Ilse
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA881122B publication Critical patent/ZA881122B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
ZA881122A 1987-02-19 1988-02-18 Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders ZA881122B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873705220 DE3705220A1 (de) 1987-02-19 1987-02-19 Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom

Publications (1)

Publication Number Publication Date
ZA881122B true ZA881122B (en) 1989-10-25

Family

ID=6321287

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881122A ZA881122B (en) 1987-02-19 1988-02-18 Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders

Country Status (7)

Country Link
EP (1) EP0279357A2 (da)
JP (1) JPS63222115A (da)
KR (1) KR880009648A (da)
DE (1) DE3705220A1 (da)
DK (1) DK83688A (da)
HU (1) HU200941B (da)
ZA (1) ZA881122B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931464A (en) * 1989-02-15 1990-06-05 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
DE3926606A1 (de) * 1989-08-11 1991-02-14 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Also Published As

Publication number Publication date
DK83688A (da) 1988-08-20
HU200941B (en) 1990-09-28
DK83688D0 (da) 1988-02-18
KR880009648A (ko) 1988-10-04
JPS63222115A (ja) 1988-09-16
DE3705220A1 (de) 1988-09-01
HUT47222A (en) 1989-02-28
EP0279357A2 (de) 1988-08-24

Similar Documents

Publication Publication Date Title
GB2157178B (en) Apparatus for treating disorders of cardiac rhythm
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
EP0467164A3 (en) Use of the compound flupirtine against muscle bracing
IL83925A0 (en) Compositions for treatment of skin disorders
HU896626D0 (en) Process for the preparation of heterocyclic compounds
EP0179808A4 (en) MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS.
PT79220A (en) Process for preparing new pyridoindole derivatives useful as agents for the treatment of diseases of the centrel nervous system
JPS6448864A (en) Continuous finish treatment for aqueous crude dye suspension
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
DE3460620D1 (en) Pharmaceutical or veterinary composition for the treatment of ischemic cardiac disorders
ZA886247B (en) Use of a compound for the treatment of schizophrenia
YU238288A (en) Process for obtaining substituted derivatives of stirene
ZA881122B (en) Use of n-substituted heterocyclic compounds as agents for treating coronary or cerebral disorders
EP0288685A3 (en) Use of pyrrolidone derivatives as anti-amnestic agents
ZA907702B (en) The use of alkylphosphoric acid compounds for combatting psoriasis disorders
ZA817931B (en) Compounds and method for treatment or prophylaxis of cardiac disorders
EP0303232A3 (en) Use of benzylpyridine derivatives for the treatment of dementia
ZA884835B (en) Treatment of cerebral disorders
HU8905409D0 (en) Process for the preparation of compositions containing ace inhibitor suitable for the treatment of postischaemic cardiac disturbances
GB2272155B (en) Piperazine derivatives for treatment of cognitive disorders
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
GB2195532B (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
NZ255753A (en) Use of substituted azaspiranes for psoriasis treatment
AU9122591A (en) N-substituted n-(alpha-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders
GB2167067B (en) Process for stabilization of bacampicillin hydrochloride